These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29405203)

  • 1. Diagnosis: CancerSEEK and destroy - a blood test for early cancer detection.
    Killock D
    Nat Rev Clin Oncol; 2018 Mar; 15(3):133. PubMed ID: 29405203
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection and localization of surgically resectable cancers with a multi-analyte blood test.
    Cohen JD; Li L; Wang Y; Thoburn C; Afsari B; Danilova L; Douville C; Javed AA; Wong F; Mattox A; Hruban RH; Wolfgang CL; Goggins MG; Dal Molin M; Wang TL; Roden R; Klein AP; Ptak J; Dobbyn L; Schaefer J; Silliman N; Popoli M; Vogelstein JT; Browne JD; Schoen RE; Brand RE; Tie J; Gibbs P; Wong HL; Mansfield AS; Jen J; Hanash SM; Falconi M; Allen PJ; Zhou S; Bettegowda C; Diaz LA; Tomasetti C; Kinzler KW; Vogelstein B; Lennon AM; Papadopoulos N
    Science; 2018 Feb; 359(6378):926-930. PubMed ID: 29348365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early diagnosis of cancer with capillary dynamic blood test].
    KAELIN W
    Hippokrates; 1952 Sep; 23(18):495-501. PubMed ID: 12999142
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE FOLIC ACID TEST. ATTEMPT AT EARLY DETECTION OF CANCER].
    DESPIERRES G
    Poumon Coeur; 1965; 21():169-75. PubMed ID: 14306372
    [No Abstract]   [Full Text] [Related]  

  • 5. New Blood Test SEEKs To Detect and Localize Cancer before It's Too Late.
    Bogyo M; Yim JJ; Rosenthal EL
    Biochemistry; 2018 Mar; 57(10):1561-1562. PubMed ID: 29489339
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood Test for Cancer: Are We There Yet?
    Troyer D
    Eur Urol; 2021 Jun; 79(6):772-773. PubMed ID: 33674181
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Liquid biopsy' for cancer promises early detection.
    Kaiser J
    Science; 2018 Jan; 359(6373):259. PubMed ID: 29348215
    [No Abstract]   [Full Text] [Related]  

  • 8. [PSA and blood test diagnostics of prostate cancer].
    Seikkula H; Pettersson K; Boström PJ
    Duodecim; 2015; 131(17):1547-52. PubMed ID: 26548101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein corona-enabled blood test for early cancer detection.
    Caputo D; Papi M; Coppola R; Palchetti S; Digiacomo L; Caracciolo G; Pozzi D
    Nanoscale; 2017 Jan; 9(1):349-354. PubMed ID: 27924334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold nanoparticle-enabled blood test for early stage cancer detection and risk assessment.
    Zheng T; Pierre-Pierre N; Yan X; Huo Q; Almodovar AJ; Valerio F; Rivera-Ramirez I; Griffith E; Decker DD; Chen S; Zhu N
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6819-27. PubMed ID: 25757512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting.
    Werner S; Krause F; Rolny V; Strobl M; Morgenstern D; Datz C; Chen H; Brenner H
    Clin Cancer Res; 2016 Apr; 22(7):1725-33. PubMed ID: 26561557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating and disseminated tumor cells in the management of breast cancer.
    Ross JS; Slodkowska EA
    Am J Clin Pathol; 2009 Aug; 132(2):237-45. PubMed ID: 19605818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Schmidt J
    MMW Fortschr Med; 2023 Oct; 165(Suppl 3):16. PubMed ID: 37857951
    [No Abstract]   [Full Text] [Related]  

  • 14. [POSSIBILITY OF AN EARLY DIAGNOSIS OF CANCER THROUGH HEMATOLOGIC MEANS].
    SCHELLER EF
    Minerva Med; 1965 May; 56():1451-2. PubMed ID: 14295072
    [No Abstract]   [Full Text] [Related]  

  • 15. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
    Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
    Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of the presence of enzymes in the blood serum of cancer patients and its advantages in hematological research in the early diagnosis of cancer].
    LYNKONES S
    Hell Iatr; 1961 Dec; 30():1401-5. PubMed ID: 14467602
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE HEMATOLOGIC MALIGNOLIPIN "TEST" FOR EARLY DIAGNOSIS OF MALIGNANT TUMORS].
    NUVOLI U; CASSARINO U
    Riforma Med; 1964 Nov; 78():1249-52. PubMed ID: 14226859
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.
    Baxter NT; Koumpouras CC; Rogers MA; Ruffin MT; Schloss PD
    Microbiome; 2016 Nov; 4(1):59. PubMed ID: 27842559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
    Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
    Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.